Envestnet Asset Management
PACB icon

Envestnet Asset Management’s Pacific Biosciences PACB Stock Holding History

Envestnet Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Sell
132,926
-16,035
-11% -$23.3K ﹤0.01% 4600
2026
Q1 		$197K Buy
148,961
+44,340
+42% +$79.3K ﹤0.01% 4515
2025
Q4 		$196K Sell
104,621
-36,347
-26% -$69.8K ﹤0.01% 4278
2025
Q3 		$180K Sell
140,968
-8,773
-6% -$11.9K ﹤0.01% 4341
2025
Q2 		$186K Sell
149,741
-13,741
-8% -$15.9K ﹤0.01% 4252
2025
Q1 		$193K Buy
163,482
+23,359
+17% +$35.8K ﹤0.01% 4148
2024
Q4 		$256K Sell
140,123
-18,047
-11% -$35.2K ﹤0.01% 3973
2024
Q3 		$269K Buy
158,170
+41,792
+36% +$68.7K ﹤0.01% 3881
2024
Q2 		$159K Sell
116,378
-9,129
-7% -$18.4K ﹤0.01% 3986
2024
Q1 		$471K Sell
125,507
-3,522
-3% -$20.6K ﹤0.01% 3477
2023
Q4 		$1.27M Buy
129,029
+75,890
+143% +$621K ﹤0.01% 2756
2023
Q3 		$444K Buy
53,139
+18,597
+54% +$213K ﹤0.01% 3315
2023
Q2 		$459K Buy
34,542
+9,936
+40% +$121K ﹤0.01% 3263
2023
Q1 		$285K Buy
24,606
+1,238
+5% +$12.3K ﹤0.01% 3468
2022
Q4 		$191K Buy
23,368
+1,617
+7% +$13.9K ﹤0.01% 3684
2022
Q3 		$126K Buy
21,751
+403
+2% +$2.31K ﹤0.01% 3696
2022
Q2 		$94K Buy
21,348
+1,896
+10% +$11.5K ﹤0.01% 3761
2022
Q1 		$177K Sell
19,452
-573
-3% -$6.6K ﹤0.01% 3722
2021
Q4 		$410K Buy
+20,025
New +$483K ﹤0.01% 3197

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Envestnet Asset Management's PACB Position: Q2 2026 in Review

Envestnet Asset Management reduced its Pacific Biosciences (PACB) stake by 11% in Q2 2026, selling an estimated $23.3K and leaving 132,926 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #4600.

Envestnet Asset Management first reported a position in PACB in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.27M in Q4 2023. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Envestnet Asset Management held 132,926 shares of Pacific Biosciences worth $223K as of Q2 2026.
  • Envestnet Asset Management sold 16,035 Pacific Biosciences shares in Q2 2026, an estimated $23.3K.
  • Pacific Biosciences made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4600 holding.
  • Envestnet Asset Management first reported a position in Pacific Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Envestnet Asset Management's Pacific Biosciences position peaked at $1.27M in Q4 2023.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.